Your session is about to expire
← Back to Search
Rehabilitation Program for Spastic Ataxia
N/A
Recruiting
Research Sponsored by Université du Québec à Chicoutimi
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have a confirmed genetic diagnosis of ARSACS or SPG7
Be able to maintain standing position and to transfer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 consecutives days, 2 times
Awards & highlights
Summary
This trial aims to evaluate the effectiveness of a 12-week rehabilitation program called IMPACT on individuals with spastic ataxias. Spastic ataxias are diseases that cause walking difficulties and balance issues
Who is the study for?
This trial is for individuals with spastic ataxias, a group of conditions causing walking difficulties and balance problems. Participants should have these symptoms but not be undergoing any other specific treatments for them during the trial.
What is being tested?
The study tests a 12-week supervised rehabilitation program called IMPACT, designed to reduce disease severity in spastic ataxias compared to usual care. It also examines how well this program can be implemented in clinical settings and its cost-effectiveness.
What are the potential side effects?
Since IMPACT is a non-pharmacological rehab program focusing on exercise and physical therapy, side effects may include muscle soreness or fatigue due to increased activity levels.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have a genetic diagnosis of ARSACS or SPG7.
Select...
I can stand and move from one place to another on my own.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 7 consecutives days, 2 times
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 consecutives days, 2 times
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Severity of ataxia
Secondary outcome measures
Activities of Daily Living
Anxiety and Depression
Ataxia impact scale
+33 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
The intervention group will follow a 12-week rehabilitation program, 3 times a week (two sessions in a therapy room and one session of aquatherapy).
Group II: Control groupActive Control1 Intervention
The control group will receive their usual care and will be asked to continue their usual activities and exercises for the whole project duration. Only one clinical guide exists for ataxia interventions and no specific guidelines for physiotherapy and occupational therapy interventions are specified in this guide in terms of frequency, duration and type of interventions that are effective with this population. Patients generally have an annual follow-up with a doctor or a clinical nurse at a Neuromuscular Diseases Clinic. Patients are then referred if needed for follow-up with the physiotherapist and occupational therapist. Typically, patients are referred to physiotherapy for mobility-related needs such as the introduction of a walking aid, orthotic and sometimes teaching an exercise program. In occupational therapy, patients are referred for needs such as the introduction of technical aids, home adaptation or the introduction of a wheelchair.
Find a Location
Who is running the clinical trial?
Centre intégré universitaire de santé et de services sociaux du Saguenay-Lac-St-JeanUNKNOWN
Integrated University Health and Social Services Center of the Capitale-NationaleOTHER
4 Previous Clinical Trials
499 Total Patients Enrolled
Corporation de recherche et d'action sur les maladies héréditaires (CORAMH)UNKNOWN
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger